The old computer has been
inactivated due to outdated hardware.
这台旧电脑因为硬件过时而被停用。
Her membership card was
inactivated after she failed to renew it on time.
她的会员卡因为没有按时续费而失效。
The inactive volcano hasn't erupted for centuries.
这座休眠火山已经好几个世纪没有喷发了。
The unused account has been
inactivated to prevent unauthorized access.
这个未使用的账户已被停用以防止未经授权的访问。
The employee's sick leave has been
inactivated, and they must return to work tomorrow.
员工的病假已失效，他们必须明天返回工作岗位。
Inactivated vaccines still contain some protective components but are less effective than live ones.
灭活疫苗仍含有一些保护成分，但不如活疫苗有效。
The Wi-Fi connection was
inactivated during the power outage.
停电期间Wi-Fi连接被关闭。
The old software has been replaced, rendering its inactivation necessary.
旧软件已经被替换，因此需要停用。
The inactive mode on my phone conserves battery life when not in use.
手机的休眠模式在不使用时可以节省电池寿命。
The party's political influence has been significantly
inactivated by recent scandals.
该政党因最近的丑闻其政治影响力大为减弱。
Its flagship vaccine, the inactivated vaccine against COVID-19, has realized localized production in five countries involved in the initiative — Indonesia, Turkiye, Egypt, Malaysia and Algeria.
其旗舰疫苗新冠肺炎灭活疫苗已在印度尼西亚、土耳其、埃及、马来西亚和阿尔及利亚五个参与该倡议的国家实现了本地化生产。
Sinopharm is the only enterprise in the world to have independently developed four COVID-19 vaccines via three technical platforms－two inactivated vaccines, one genetic recombinant vaccine and one mRNA vaccine.
国药集团是世界上唯一一家通过三个技术平台自主研发4种新冠肺炎疫苗的企业——两种灭活疫苗、一种基因重组疫苗和一种mRNA疫苗。
Sinopharm is the only enterprise in the world that has independently developed four COVID-19 vaccines via three technical platforms -- two inactivated vaccines, one genetic recombinant vaccine and one mRNA vaccine.
国药集团是全球唯一一家通过两种灭活疫苗、一种基因重组疫苗和一种mRNA疫苗三大技术平台自主研发四种新冠肺炎疫苗的企业。
Sinovac Biotech Ltd, a biopharmaceutical product provider in China, announced on Tuesday that a phase-3 clinical trial for its inactivated quadrivalent influenza vaccine was initiated in the Republic of Chile.
中国生物制药产品供应商科兴生物技术有限公司周二宣布，其四价流感灭活疫苗的三期临床试验已在智利共和国启动。
Chinese vaccine producer Sinovac Biotech officially kicked off a clinical trial in Hong Kong on Monday to assess the safety and immunogenicity of its Omicron-specific COVID-19 inactivated vaccine which will be used as a booster shot in healthy adults.
中国疫苗生产商科兴生物周一在香港正式启动临床试验，以评估其奥密克戎特异性新冠肺炎灭活疫苗的安全性和免疫原性，该疫苗将用于健康成年人的加强针。
The trial program plans to recruit around 300 or more healthy volunteers who are above the age of 18 and who have already been inoculated with two or three shots of either inactivated or mRNA COVID-19 vaccine.
该试验计划招募约300名或更多18岁以上的健康志愿者，他们已经接种了两针或三针新冠肺炎灭活疫苗或mRNA疫苗。
Sinovac obtained a sample of the Omicron variant in early December last year to further the research and development of its Omicron-specific inactivated COVID-19 vaccine.
去年12月初，科兴获得了奥密克戎变异株的样本，以进一步研发其奥密克龙特异性新冠肺炎灭活疫苗。
Back in June 2020, China and the United Arab Emirates started to conduct phase 3 clinical trials of an inactivated COVID-19 vaccine in the UAE.
早在2020年6月，中国和阿拉伯联合酋长国就开始在阿联酋进行新冠肺炎灭活疫苗的3期临床试验。
China National Biotec Group has suggested Chinese authorities offer the public an additional third shot of its COVID-19 inactivated vaccines as a booster shot, according to a senior executive of the company.
中国国药集团一名高层主管表示，中国国药集团已建议中国监管机构向公众提供第三剂新冠灭活疫苗作为加强针。这是该翻译的中文版本。具体来说，这句话可以被翻译为："中国国药集团的一位高级管理人员表示，该公司已经提议中国当局向公众提供其新冠灭活疫苗的第三剂作为加强针。" 这意味着中国国药集团正在推动第三剂疫苗的使用，以增强公众对新冠病毒的免疫力。
During an exclusive interview with China Daily on Sunday during the 2021 China International Fair for Trade in Services, held in Beijing from Sep 2 to 7, Chen Kun, secretary of the commission for discipline inspection at CNBG, said trials have shown the company's two inactivated vaccines can effectively protect people from existing mainstream strains of the new coronavirus.
在中国国际服务贸易交易会期间，中国生物技术集团有限公司纪委委员陈坤在接受中国日报独家采访时说，试验显示，该公司两种灭活疫苗能够有效抵御现有的主要新冠病毒变异株。2021年中国国际服务贸易交易会于9月2日至7日在北京举行。
The bioscience subsidiary of State-owned healthcare company Sinopharm, CNBG has been conducting research and development in different types of COVID-19 vaccines via inactivated, recombinant and mRNA technologies.
国药集团旗下的生物科学子公司CNBG一直在通过灭活、重组和mRNA技术研究和开发不同类型的COVID-19疫苗。这里将英文句子翻译成
That includes the updated versions of its two approved inactivated vaccines, two vaccine candidates under development via recombinant and mRNA technologies, and three test kits.
这包括其两款获批的灭活疫苗的更新版本，以及通过重组技术和mRNA技术开发的两种候选疫苗，还有三款检测试剂盒。
Chinese authorities gave conditional market approval for each of CNBG's two inactivated vaccines last December and this February.
中国监管当局去年12月和今年2月分别有条件批准了国药集团的两款灭活疫苗上市。
Bangladesh will be able to produce 5 million doses of Sinopharm's inactivated COVID-19 vaccines monthly, according to a memorandum of understanding signed virtually from Beijing and Dhaka on Monday.
根据周一在北京和达卡线上签署的谅解备忘录，孟加拉国每月将能够生产500万剂中国国药集团的灭活新冠疫苗。
Instead of mRNA vaccines, only inactivated COVID-19 vaccines are used in China at present.
目前，中国只使用灭活COVID-19疫苗，而不是mRNA疫苗。
Surging export orders show China's pharma products are trusted overseasAt Sinovac Biotech Ltd's base in Daxing district of Beijing, employees are busy manufacturing CoronaVac, the inactivated COVID-19 vaccine, in bulk.
在北京市大兴区科兴中维生物技术有限公司基地，工人们正忙着大批量生产CoronaVac灭活新冠疫苗。这家公司的出口订单激增，显示出中国医药产品在海外受到信赖。
Among these are three inactivated vaccines and one adenovirus vector vaccine in phase-three trials overseas.
其中包括三种灭活疫苗和一种腺病毒载体疫苗，它们都在海外处于三期试验阶段。
One of the inactivated vaccines is from Beijing-based drugmaker Sinovac Biotech Ltd. China National Biotech Group, a unit of State-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is developing the other two inactivated candidates.
其中一款灭活疫苗来自北京生物技术公司科兴中维。中国国药集团旗下的中国生物技术公司正在研发另外两款灭活疫苗。
According to a statement from China National Biotech Group Co Ltd, Sinopharm's vaccine and bioscience unit, Phase-1 and Phase-2 clinical trials of its inactivated vaccine have shown a 100 percent antibody-positive conversion rate, demonstrating good performance in safety and effectiveness on volunteers, with no subjects showing serious adverse reactions.
The group's inactivated vaccine is among the world's first batch to acquire clinical trial approval, and the results collected are the world's first clinical data on safety and effectiveness after two doses of vaccination, offering scientific and measurable support for epidemic prevention and control and emergency use, industry insiders said.
Although the vaccine is inactivated, the antigenic compound it contains can stimulate production of antibodies in humans.
"The results of the Phase-1 and Phase-2 clinical trials of the inactivated vaccine are encouraging," said Chen Qiaoshan, a medical analyst at Beijing-based market consultancy Analysys.
CNBG said that once three trials for the inactivated vaccine are completed, the product should hit the market by the end of this year or early 2021.
"On Feb 1, Sinopharm launched the "2019-nCov Inactivated Vaccine" project and researchers began working on the vaccine.
On April 12, the inactivated vaccine was approved for clinical trials by the National Medical Products Administration, being the first inactivated vaccine worldwide to reach such a developed approval stage.
CNBG launched Phase-2 human trials of its first inactivated vaccine on April 24.
The world's first inactivated vaccine has shown a 100 percent antibody positive conversion rate, with all subjects producing antibodies according to the latest clinical results from its producer.
China National Biotech Group Co Ltd, Sinopharm's vaccine and bioscience unit, announced on Tuesday the phase-1 and phase-2 clinical trials of its inactivated vaccine had demonstrated good performance in safety and effectiveness on vaccinated volunteers.
Chen Qiaoshan, a medical analyst at Beijing-based market consultancy Analysys, said: "The results of the phase-1 and phase-2 clinical trials of the inactivated vaccine were encouraging.
Once the inactivated vaccine completes the three trials, it is expected to hit the market by the end of this year or the beginning of next year.
On April 24, CNBG launched phase-2 human trials of its first inactivated vaccine, which was codeveloped by the Wuhan Institute of Biological Products and the Wuhan Institute of Virology under the Chinese Academy of Sciences.
The product, which was approval for clinical trials on April 12, was the first inactivated vaccine worldwide to reach such a developed approval stage.
China National Biotech Group Co Ltd, Sinopharm's vaccine and bioscience unit, announced on Monday that its second inactivated vaccine targeting the contagion won clinical trial approval from the National Medical Products Administration.
中国生物技术集团公司（Sinopharm的疫苗和生物科技部门）在周一宣布，其研发的第二款针对该传染病的灭活疫苗已获得国家药品监督管理局的临床试验批准。
On Friday, CNBG launched phase-2 human trials of its first inactivated vaccine, which is codeveloped by its unit, the Wuhan Institute of Biological Products, along with the Wuhan Institute of Virology under the Chinese Academy of Sciences.
上周五，中国生物集团启动了其首款灭活疫苗的二期人体临床试验，该疫苗由其下属的武汉生物制品研究所与隶属于中国科学院的武汉病毒研究所共同研发。
Approved for clinical trials on April 12, the vaccine was the first inactivated vaccine worldwide to reach such a developed approval stage.
这款疫苗于4月12日获批进入临床试验阶段，是全球首款进入如此高级别审批阶段的灭活疫苗。
Yang said it is quite encouraging to have developed inactivated vaccines against COVID-19.
Inactivated vaccines use nonliving viruses, bacteria or other pathogens that have lost disease-producing capacity to stimulate the immune system to develop an immune response.
Wang Junzhi, an academic at the Chinese Academy of Engineering, said China has laid a solid foundation to research inactivated vaccines in recent years, and inactivated vaccines have been widely used to fight hepatitis A, influenza, poliomyelitis, and hand, foot and mouth disease.
The vaccine, co-developed by the company's subsidiary, China National Biotech Group Co Ltd, and the Wuhan Institute of Virology under the Chinese Academy of Science, was the first inactivated vaccine against the novel coronavirus approved for clinical trials globally, the company said, which also is known as China National Pharmaceutical Group Co.
"We are also working around the clock to develop inactivated vaccines.
Sinopharm is also known as China National Pharmaceutical Group Co. Two affiliates of China National Biotech Group Co Ltd (CNBG), Sinopharm's subsidiary for vaccine and biological medicine, are working around the clock developing inactivated vaccines, and the Wuhan subsidiary in Hubei province is currently cultivating the virus, while the Beijing subsidiary is building the virus seed stock together with Chinese Center for Disease Control and Prevention.
China National Pharmaceutical Group Co Ltd, or Sinopharm, announced recently it had developed four Omicron-specific vaccine candidates, including inactivated, recombinant protein, and mRNA varieties, as well as an inhalable monoclonal antibody for COVID-19 prevention.
The company successfully developed the world's first inactivated COVID-19 vaccine in 2020, which has been approved for use by more than 119 countries, regions and international organizations with supplies totaling more than 3.5 billion doses worldwide.
On Feb 9, Shanghai-based Aichong Biotechnology announced that its inactivated feline triple vaccine had entered its clinical trial stage.
Will make vaccines available to COVAX participants in global COVID-19 fightAt a time when the Delta variant is posing a rising risk to health systems, Gavi, the Vaccine Alliance, has recently announced advance purchase agreements with Chinese drugmakers Sinopharm and Sinovac for their inactivated virus vaccines against COVID-19.
在全球应对COVID-19疫情、Delta变异株对医疗系统构成日益严重威胁的当下，疫苗联盟Gavi近日宣布已与中国药企国药集团（Sinopharm）和科兴生物（Sinovac）签署预购协议，采购其针对COVID-19的灭活病毒疫苗，以供COVAX参与者使用。
"The export of our COVID-19 vaccines helped us gain international recognition and credibility, which in turn contributed to the export of the company's other vaccine-related products," said Pearson Liu, director of brand management and public relations at Sinovac Biotech Ltd. For example, since 2009, Sinovac has been promoting the clinical trials and registration of its inactivated vaccine against hepatitis A in South Korea.
Sinovac Biotech Ltd的品牌管理和公关总监Pearson Liu表示：“我们COVID-19疫苗的出口帮助我们在国际上获得了认可和信誉，这反过来又促进了公司其他与疫苗相关产品的出口。”例如，自2009年以来，Sinovac一直在韩国推动其灭活型甲型肝炎疫苗的临床试验和注册。
That enabled Sinovac to function round the clock and produce hundreds of thousands of doses of CoronaVac vaccine, an inactivated COVID-19 vaccine.
这使得Sinovac能够全天候运转，并生产数十万剂CoronaVac疫苗，这是一种灭活的COVID-19疫苗。
In the workshop, an inactivated vaccine targeting COVID-19 is being produced and inspected.
According to the owner of the institute, China National Biotech Group Co Ltd, Sinopharm's vaccine and bioscience unit, the phase-2 human trials of its inactivated vaccine at the Beijing Institute, as well as the Wuhan Institute of Biological Products, are under way, and more than 2,000 volunteers have been vaccinated.
Along with the production at the Wuhan Institute, the total yearly output can reach 200 million doses, fully guaranteeing the accessibility of the inactivated vaccine, he said.
On April 24, CNBG launched phase-2 human trials of its first inactivated vaccine, which is codeveloped by the Wuhan Institute of Biological Products and the Wuhan Institute of Virology under the Chinese Academy of Sciences.
The product, which got approval for clinical trials on April 12, was the first inactivated vaccine worldwide to reach such a developed approval stage.
On April 27, CNBG's second inactivated vaccine for COVID-19 was approved by the NMPA.
As CNBG is experienced in inactivated vaccines and has various related marketed products, the company chose to work on an inactivated vaccine.
Further afield, according to Zhang, they will inactivate non-performing stores and revamp big, efficient outlets and some self-operated ones in key cities, including Beijing, Hangzhou and Shenyang.
A dynamic air-and-surface disinfection technology system that can inactivate COVID-19 will also feature.
In 2020, Sinopharm successfully developed the world's first inactivated COVID-19 vaccine, which over the past several years has been approved for use in more than 119 countries, regions and international organizations.
未经许可，严禁转发。QQ交流群：688169419